# Sprint 60 evidence: synthetic encounter finalization

Status: Implemented and automated verification complete; all clinical, legal, billing, claims, integration, accessibility, security, operational, and production approvals remain open

Decision: [TH-DEC-0063](../decisions/0063-approved-sprint-60-synthetic-encounter-finalization.md)

Plan: [Sprint 60 synthetic encounter finalization](sprint-60-synthetic-encounter-finalization.md)

## Implemented boundary

- The exact owning physician may create the existing governed immutable encounter lock only after confirming the current complete SOAP, safety-disposition, and source-bound final clinical review.
- The source recheck is part of the locked transaction and includes the current optional signed-prescription order binding.
- The response and UI identify this as a NON_PRODUCTION synthetic lock with no legal, completion, delivery, billing, claim, integration, or external consequence.
- The consultation remains in `WrapUp`; the physician remains unavailable. No lifecycle release was implemented.

## Automated evidence

- Backend suite: 768 tests passed.
- Focused UI: finalization and final-clinical-review component tests passed (3 tests); TypeScript build passed.
- Runtime safety: all checks passed, including in-transaction ownership/source validation and current prescription-order binding.
- Live local API: OpenAPI and authorization suites passed against an explicitly enabled synthetic API; migration/recovery, planning, and Graphify portability checks passed.

## Open gates

Atomic visit completion and clinician release, legal signing policy, appointment fulfillment, AVS/patient delivery, coding and human billing review, claim creation/submission, payer/clearinghouse transport, pharmacy delivery, independent review, and production remain open.
